Amar Krishnaswamy, MD, shared his thoughts on this important technology in an exclusive interview. 

Researchers focused on rates of venous thromboembolism among COVID-19 patients at their own health system, sharing their work in JAMA Network Open.

The analysis included outcomes data from nearly 1,500 PCI patients. 

The full analysis was published in Circulation: Heart Failure. 

The Disrupt BTK II study will include 250 patients overall. 

The study, published in the Journal of the American Heart Association, examined how certain symptoms related to depression might be associated with a person's risk of HFpEF and HFrEF.

The new analysis showed why women struggling to fully recover from COVID-19 may benefit from a targeted rehab program. 

The agency said a final decision will be made by April 2022. 

The business magazine Fast Company is out with its picks for the “next big things in tech.” Of 65 companies making the overall list for 2021, the project’s inaugural year, 10 of the best are in healthcare.